SCHEMBL19086224

SCHEMBL19086224

CC(C)(C)OC(=O)NCC(=O)N1CCc2sc(C=O)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.42
SIGMAR1 Q99720 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
FNTA P49354 2/20 0.41
FNTB P49356 2/20 0.41
KDM1A O60341 3/20 0.36
NAMPT P43490 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ESR2 Q92731 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
NR1H2 P55055 1/20 0.35
MMP1 P03956 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19086993 0.85 HDAC6 (0.49) HDAC6SIGMAR1ALDH1A1MEN1TSHR
SCHEMBL19086215 0.82 HDAC6 (0.49) HDAC6SIGMAR1ALDH1A1MEN1TSHR
SCHEMBL2923721 0.82 ESR2 (0.53) HDAC6NAMPTESR2NR1H2BRD4
SCHEMBL3555661 0.74 NOTUM (0.47) HDAC6ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL2921885 0.73 MAPT (0.44) HDAC6ALDH1A1MEN1TSHRKMT2A
SCHEMBL31486552 0.73 HDAC1 (0.44) NAMPTSMN1; SMN2ESR2NR1H2BRD4
SCHEMBL4815544 0.72 ESR2 (0.53) HDAC6ESR2NR1H2BRD4CREBBP
SCHEMBL3441635 0.72 HDAC6 (0.43) HDAC6ALDH1A1MEN1KMT2AKDM1A
SCHEMBL6230603 0.71 NAMPT (0.59) SIGMAR1ALDH1A1MEN1TSHRKMT2A
SCHEMBL19086019 0.71 ALDH1A1 (0.41) HDAC6ALDH1A1KDM1AL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017114275-A1 COMPOUND FOR INHIBITING ROCK, PREPARATION METHOD AND USE OF SAME 成都先导药物开发有限公司 2017-07-06 WO disclosed